Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SGMT US Equity

Sagimet Biosciences Inc.Health Care · Pharmaceutical Preparations · CIK 1400118 · FY ends Dec 31
$10.58
+0.00 (+0.00%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-08-138-K 8.01Other eventssec.gov ↗
2026-08-118-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-218-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-21

Every row is a filed document, checked against its EDGAR index.